Virginia Estate & Retirement Planning Advisors’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Virginia Estate & Retirement Planning Advisors’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-401	Closed	-$37.7K	–	193
2026 Q1	$37.7K	Buy	+401	New	+$35.1K	0.07%	33

Other funds holding IHE

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

IWS

Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

Virginia Estate & Retirement Planning Advisors's IHE Position: Q2 2026 in Review

Virginia Estate & Retirement Planning Advisors sold out of iShares US Pharmaceuticals ETF (IHE) in Q2 2026, closing a stake of 401 shares — an estimated $37.7K sold.

Virginia Estate & Retirement Planning Advisors first reported a position in IHE in Q1 2026 and held it in 1 quarter. The position peaked at $37.7K in Q1 2026. 209 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

Virginia Estate & Retirement Planning Advisors reported no remaining iShares US Pharmaceuticals ETF position as of Q2 2026 after selling out during the quarter.
Virginia Estate & Retirement Planning Advisors sold 401 iShares US Pharmaceuticals ETF shares in Q2 2026, an estimated $37.7K.
Virginia Estate & Retirement Planning Advisors first reported a position in iShares US Pharmaceuticals ETF in Q1 2026 and held it in 1 quarter.
Virginia Estate & Retirement Planning Advisors's iShares US Pharmaceuticals ETF position peaked at $37.7K in Q1 2026.
209 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on Virginia Estate & Retirement Planning Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.